Primemd Inc.
PRMD · OTC
12/31/2021 | 3/31/2008 | 3/31/2007 | 3/31/2006 | |
|---|---|---|---|---|
| Market Cap | $4,625 | $277 | $676 | $553 |
| - Cash | $2,590 | $416 | $550 | $751 |
| + Debt | $7,134 | $123 | $0 | $0 |
| Enterprise Value | $9,168 | -$16 | $126 | -$198 |
| Revenue | $10,502 | $68 | $49 | $53 |
| % Growth | 15,388.8% | 38% | -6.6% | – |
| Gross Profit | $10,502 | $68 | $49 | $53 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $3,427 | -$104 | -$212 | -$158 |
| % Margin | 32.6% | -153% | -432.3% | -300.1% |
| Net Income | $3,140 | -$101 | $195 | -$156 |
| % Margin | 29.9% | -149.1% | 396.2% | -295.4% |
| EPS Diluted | 0.17 | -0.033 | 0.063 | -0.051 |
| % Growth | 616.7% | -151.9% | 225.3% | – |
| Operating Cash Flow | $3,017 | -$91 | -$162 | -$136 |
| Capital Expenditures | -$776 | $0 | $0 | $0 |
| Free Cash Flow | $2,241 | -$91 | -$162 | -$136 |